Jane Street Group LLC Lowers Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

Jane Street Group LLC lessened its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 52.2% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 8,273 shares of the company’s stock after selling 9,018 shares during the quarter. Jane Street Group LLC’s holdings in Addus HomeCare were worth $1,101,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the stock. Texas Permanent School Fund Corp boosted its stake in Addus HomeCare by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock worth $1,636,000 after buying an additional 82 shares during the period. Arizona State Retirement System boosted its stake in shares of Addus HomeCare by 2.0% in the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after purchasing an additional 87 shares during the period. Inspire Investing LLC boosted its stake in shares of Addus HomeCare by 3.3% in the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock valued at $414,000 after purchasing an additional 100 shares during the period. New York State Teachers Retirement System boosted its stake in shares of Addus HomeCare by 1.2% in the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock valued at $1,132,000 after purchasing an additional 100 shares during the period. Finally, Equitable Trust Co. boosted its stake in shares of Addus HomeCare by 2.2% in the third quarter. Equitable Trust Co. now owns 4,825 shares of the company’s stock valued at $642,000 after purchasing an additional 106 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. The trade was a 18.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the transaction, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is owned by corporate insiders.

Addus HomeCare Trading Down 1.5 %

ADUS stock opened at $126.28 on Tuesday. Addus HomeCare Co. has a twelve month low of $85.94 and a twelve month high of $136.12. The company’s 50 day moving average is $125.55 and its two-hundred day moving average is $125.57. The stock has a market cap of $2.29 billion, a P/E ratio of 28.90, a PEG ratio of 2.11 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter last year, the company earned $1.03 earnings per share. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. On average, equities research analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have recently commented on ADUS. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. KeyCorp assumed coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective for the company. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Finally, Oppenheimer raised their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $133.67.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.